Viewing Study NCT07303660


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 5:14 AM
Study NCT ID: NCT07303660
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-26
First Post: 2025-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1b Study of Lonitoclax + Azacitidine in Acute Myeloid Leukemia Patients
Sponsor: Lomond Therapeutics Holdings, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module